|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 37/10 | |
| A61K 31/19 | |||
| A61K 31/192 | |||
| A61K 31/485 | |||
| A61P 41/00 | |||
| A61K 9/00 | |||
| A61K 9/08 |
| (11) | Patento numeris | 2405748 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10751461.4 |
| Europos patento paraiškos padavimo data | 2010-03-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-01-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/027096 |
| Data | 2010-03-12 |
| (87) | Numeris | WO 2010/105129 |
| Data | 2010-09-16 |
| (30) | Numeris | Data | Šalis |
| 159585 P | 2009-03-12 | US |
| (72) |
PAVLIV, Leo, US
|
| (73) |
Cumberland Pharmaceuticals Inc.,
2525 West End Avenue Suite 950, Nashville, TN 37203,
US
|
| (54) | ADMINISTRATION OF INTRAVENOUS IBUPROFEN |
| ADMINISTRATION OF INTRAVENOUS IBUPROFEN |